GD0039: Began Phase I/II trial

GlycoDesign Inc., Toronto, Ontario Product: GD0039 Business: Cancer Therapeutic category: Glycosylation, Adjunct Target: Carbohydrate processing enzymes Description: Carbohydrate processing enzyme inh...